|
|
||||||||
J Thorac Cardiovasc Surg 2005;130:888-889
© 2005 The American Association for Thoracic Surgery
Brief Communication |
a Division of Pediatric Cardiac Surgery, Stanford University School of Medicine, Stanford, Calif.
b Department of Pathology, Stanford University School of Medicine, Stanford, Calif.
c Division of Pediatric Cardiology, Stanford University School of Medicine, Stanford, Calif.
Received for publication January 19, 2005; accepted for publication February 8, 2005. * Address for reprints: Kimberly Lynn Gandy, MD, PhD, 300 Pasteur Dr, Falk Cardiovascular Research Institute, Stanford University Medical Center, Palo Alto, CA 94305 (Email: kimberly{at}stanford.edu).
Cardiac tumors in infancy are rare, with an incidence of less than 1 in 10,000. The types of cardiac tumors found in adults differ from those found in children, with myxomas being the most common tumors found in adults and rhabdomyomas being the most common tumors found in children. We report a case of a rare intracardiac tumor, an inflammatory myofibroblastic tumor, in a 2-month-old child, this being the eighth reported case in the literature. We also review the differential diagnosis and treatment of cardiac tumors in children, with specific reference to the role of echocardiography.
Clinical Summary
A 2-month-old, asymptomatic 5.6-kg girl had a heart murmur. Preoperative echocardiography documented a solitary 2 x 2.5 cm mass attached to the right atrial free wall (Figure 1, A and C). There was no associated superior or inferior vena caval obstruction, although the tumor appeared to obstruct the tricuspid orifice. No other intracardiac, visceral, or extremity soft tissue masses were appreciated. Our initial diagnosis was that of an atrial myxoma.
|
|
Discussion
Cardiac tumors are rare in children, making the analysis of incidence, clinical history, and treatment problematic. There are 2 large series of intracardiac masses reported to date, both recently reviewed by Becker.
1
Burke
2
reported a series from the Armed Forces Institute of Pathology and reported 386 tumors, 55 of which arose in infants and children. Becker reported a series from the Academic Medical Center in Amsterdam and reported 113 tumors, 21 of which originated in children. Recent case series report that rhabdomyomas are the most common tumors in infancy, with fibromas and teratomas being the second and third most common, respectively. The remaining tumors are rare and include hemangiomas, myxomas, lipomas, and Purkinje cell tumors. Primary heart tumors are rare, and metastatic lesions are 10 to 20 times more common than primary malignant tumors.
With the advances in infant echocardiography and the advent of fetal ultrasonography, an increase in primary cardiac tumors has been reported.
3
Most cardiac masses in children are now diagnosed before the second year of life, with most of the rhabdomyomas and fibromas being found in the first year of life in the aforementioned series.
1
Previous reviews reported that most rhabdomyomas were associated with the tuberous sclerosis complex and that most rhabdomyomas found in children less than 4 years of age regressed in size over time. Most reviews therefore recommend nonoperative management of asymptomatic cardiac masses in children, with the expectation that most tumors are rhabdomyomas and will regress with time.
1
Resection is recommended for cases associated with hemodynamic or respiratory compromise, severe arrhythmia, or embolic potential.
1,4
When resection is recommended, most suggest removal of as much tumor as possible while preserving cardiac function, even if some tumor is necessarily left behind.
5
The tumor described in this case report is an inflammatory myofibroblastic tumor, which is synonymous with an inflammatory pseudotumor (IPT), a rare entity with only 7 previously reported cases, as reviewed by Li and associates.
6
IPTs show a predilection for the atria, and approximately 25% recur locally,
6
most of which appear to behave in a benign fashion. These tumors never metastasize, but a small percentage show the potential for malignant transformation over time. At present, there are no reliable clinical or pathologic predictors for the behavior of IPTs. Tumors, however, that show evidence of cytologic atypia or increased mitotic activity should be treated with greater suspicion.
We believe that the treatment algorithm previously described should be modified to further reflect clinical presentation and imaging characteristics suggesting that the tumor might not be a rhabdomyoma or fibroma. When the tumor is not associated with the tuberous sclerosis complex, is solitary, involves the atrial free wall, and does not decrease in size within 2 months after diagnosis, consideration should be given to early operative excision.
Acknowledgments
We thank Jos Domen for his assistance with the illustrations.
References
This article has been cited by other articles:
![]() |
K. A. Murdison, S. Septimus, R. E. Garola, and C. Pizarro Intracardiac inflammatory myofibroblastic tumor: a unique presentation Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 750 - 752. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |